Not logged inEvaluating sensitivity of NGS-based mutation detection across diverse sample types in prostate cancer
Jiang, Kui; Dai, Zhihong; Chen, Jiaqiang; Gao, Ziping; Tong, Heyao; Liu, Hongruo; Huang, Gena; Liu, Fang; Ma, Ya; Pan, Evanki; Yin, Jiani; Yao, Lulu; Wang, Liang .png)
Share.png)
SaveAugmented reality in preoperative anterolateral thigh flap perforators positioning: A pilot diagnostic studyWei, Bin; Lu, Guoxiong; Bai, Zhiqiang; Osei-Hwedieh, David O.; Chen, Yunsheng; Li, Qunxing; Xie, Zhijun; Lu, Peichia; Miao, Jiahao; Liu, Niu; Wu, Jiaying; Lin, Hsinyu; Wu, Fan; Zhang, Lizao; Ren, Siqi; Zhu, Yingying; Mohamed, Abdo Ahmed Saleh; Dias-Ribeiro, Eduardo; Dong, Xinghui; Jiang, Kui; Li, Tianbao; Pan, Chaobin; Zhang, Bin; Hu, Huijun; Lin, Zhaoyu; Zhong, Jianglong; Fan, Song Share Save Tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR+/HER2-advanced breast cancer after CDK4/6 inhibitors: Preliminary findings of a multi-center, phase II studyZheng, Q.; Zhou, H.; Wu, H-L.; Cai, Y.; Chen, L-M.; Huang, J.; Hong, R.; Xia, W.; Jiang, K.; Xu, F.; Wang, S. Share Save Efficacy and safety of sacituzumab tirumotecan (sac-TMT) plus pembrolizumab in patients with recurrent or metastatic cervical cancerWang, J.; An, R.; Huang, Y.; Zhang, J.; Goh, J. C. H.; Jiang, K.; Yu, G.; Chen, L.; Provencher, D. M.; Tang, Y.; Li, G.; Qiu, H.; Akala, B.; Chartash, E.; Zhou, Y.; Jin, X.; Ge, J.; Wu, X. Share Save Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trialWu, Xiaohua; Liu, Jihong; Wang, Jing; Wang, Li; Lin, Zhongqiu; Wang, Xiaobin; Zhu, Jianqing; Kong, Beihua; Fei, Junwei; Tang, Ying; Xia, Bairong; Liang, Zhiqing; Wang, Ke; Huang, Yi; Zheng, Hong; Lin, An; Jiang, Kui; Wang, Wei; Wang, Xin; Lou, Ge; Pan, Hongming; Yao, Shuzhong; Li, Guiling; Hao, Min; Cai, Yunlang; Chen, Xuejun; Yang, Zhijun; Chen, Youguo; Wen, Hongwu; Qu, Pengpeng; Xu, Cong; Hsieh, Chih-Yi Share Save Efficacy and safety of senaparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer (FLAMES study): A randomized, double-blind, placebocontrolled, phase III trialWu, X.; Liu, J.; Wang, X.; Wang, J.; Wang, L.; Zhu, J.; Kong, B.; Fei, J.; Tang, Y.; Xia, B.; Liang, Z.; Wang, K.; Lin, Z.; Huang, Y.; Zheng, H.; Lin, A.; Jiang, K.; Wang, W.; Wang, X.; Lou, G. Share Save Share Save Share Save Lactobacillus spp. create a protective micro-ecological environment through regulating the core fucosylation of vaginal epithelial cells against cervical cancerFan, Qingjie; Wu, Yuanhang; Li, Mechou; An, Fan; Yao, Lulu; Wang, Meixian; Wang, Xiuying; Yuan, Jieli; Jiang, Kui; Li, Wenzhe; Li, Ming Share Save MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancerYi, Jingyan; Liu, Chongya; Tao, Zhiwei; Wang, Min; Jia, Yaxun; Sang, Xiaolin; Shen, Lanlin; Xue, Yijue; Jiang, Kui; Luo, Fuwen; Liu, Pixu; Cheng, Hailing Share Save Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traitsHao, Jiaojiao; Fan, Wenhua; Li, Yizhuo; Tang, Ranran; Tian, Chunfang; Yang, Qian; Zhu, Tianhua; Diao, Chaoliang; Hu, Sheng; Chen, Manyu; Guo, Ping; Long, Qian; Zhang, Changlin; Qin, Ge; Yu, Wendan; Chen, Miao; Li, Liren; Qin, Lijun; Wang, Jingshu; Zhang, Xiuping; Ren, Yandong; Zhou, Penghui; Zou, Lijuan; Jiang, Kui; Guo, Wei; Deng, Wuguo Share Save PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic AgentSong, Chengli; Wang, Lina; Wu, Xiaoyan; Wang, Kai; Xie, Dan; Xiao, Qi; Li, Songyu; Jiang, Kui; Liao, Lujian; Yates, John R., III; Lee, Jiing-Dwan; Yang, Qingkai Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
